MedPath

Hair2Go Label Comprehension and Usability Study

Not Applicable
Completed
Conditions
Hair Removal
Interventions
Device: Hair2Go
Registration Number
NCT01578187
Lead Sponsor
Syneron Medical
Brief Summary

The purpose of this study is to test label comprehension and usability of the hair removal device in 60 male and female participants. The study population will represent the US demographic distribution of skin types and will include varying levels of literacy.

Detailed Description

This will be a single-visit study consisting of two phases: Phase I - assessing label comprehension and Phase II - usability. For Phase I, subjects will be asked to review the outer packaging of the mē device. Each subject will be taken through an interview which will evaluate messages on the external product labeling regarding product use and self-selection criteria. Subjects, who are not self-excluders and/or contraindicated for use of the device will continue with Phase II of the study. This usability phase will consist of watching the instructional DVD, reading the User Guide and then performing a skin sensitivity test. Subjects will be expected to self-administer the hair removal treatment in a simulated home-use environment under observation of the study personnel. The users will have a telephone in the room and may call a phone number and request assistance while performing the treatment, simulating the toll-free hotline that will be available to consumers in commercial use.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  1. Males and females, between 18 and 65 years of age.
  2. Able to read and understand the written consent form.
  3. Willing to sign informed consent.
  4. Able to read and speak English.
  5. Willing and able to participate in the study procedures.
Exclusion Criteria
  1. The participant or anyone in their household is currently employed by a marketing research department or company, an advertising agency or public relations firm, a pharmaceutical company, a healthcare device manufacturer, a cosmetic or personal care company.
  2. The participant is currently employed at a salon, day spa or beauty school/college as a stylist, barber, esthetician or beauty instructor.
  3. The respondent has ever been trained or employed as a healthcare professional.
  4. The participant normally wears corrective lenses, contacts or glasses to read and does not bring them with him/her to the study site.
  5. The participant has participated in any market research study, product label study or clinical trial in the past thirty (30) days.
  6. Non-English speakers.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hair2Go deviceHair2Go-
Primary Outcome Measures
NameTimeMethod
Percent of Participants Correctly Determining Eligibility for Use of the Device (Responders)1 hour

Label comprehension will be based on responses to a questionnaire. Questions will be based on a tiered system by level of importance in responding correctly according to the following:

1. Questions regarding safe use of the system.

2. Questions regarding correct use of the system(not related to safety).

In order to demonstrate how well the label instruction, as a whole, was understood by all subjects, the proportion of subjects who correctly understood the label as a whole was calculated by classifying each subject as either a "responder" or "non-responder" based on the following criteria regarding all questions:

A subject was considered a responder if he/she correctly answered 11/12 questions related to safety AND 5/6 low category questions not related to safety.

The study was considered a success if the response rate (i.e., the proportion of subjects correctly understanding the label based on the responder criteria) was at least 90%.

Percentage of Participants Performing Critical/Non-critical Errors1-2 hours

Study staff will record the number of errors according to the following:

1. Critical error: an error that may cause a serious adverse event or an adverse event from a single occurrence

2. Non critical error: An error that, if repeated without correction/intervention, may cause an adverse event.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Consumer Product Testing Company

🇺🇸

Fairfield, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath